• Dermatology

    In the field of dermatologic medicine, Paradigm has designed and implemented CME/CE activities focused on a wide variety of areas, including Atopic Dermatitis, Acne, Acne Scarring, Actinic Keratosis, Psoriasis, Tinea Pedis, and Onychomycosis.

ADVANCES IN PSORIASIS: A CASE-BASED EXCHANGE FOCUSED ON TREATMENT CHALLENGES IN MODERATE TO SEVERE PSORIASIS

Dermatologists, along with PAs and NPs who specialize in dermatology, are at the forefront of managing psoriasis, which is estimated to affect up to 7.4 million adults in the United States. During this series of 3 live meetings, expert faculty will describe the characteristics of different severity levels of psoriasis, review appropriate treatment selection for moderate to severe psoriasis based on characteristics of available therapies and patient characteristics, and discuss effective strategies to address barriers to treatment adherence among patients with psoriasis, with the goal of improving patient outcomes.

 

RECENT ADVANCES AND EMERGING TRENDS IN ONYCHOMYCOSIS MANAGEMENT: A SERIES OF LIVE CME SATELLITE SYMPOSIA AND AN ENDURING ON-DEMAND WEBINAR

Onychomycosis - a chronic infectious disease with significant medical and psychosocial consequences - can be extremely challenging to eradicate. To manage onychomycosis effectively, clinicians need to understand the etiology, diagnosis, and management of onychomycosis as a chronic infectious disease. They must also understand the characteristics of current topical, systemic, and mechanical treatments and be able to appropriately integrate new and emerging therapies into their practice based on treatment benefits and risks and patient factors. This initiative was designed to educate dermatologic clinicians on recent advances and emerging trends in onychomycosis management based on evidence from clinical trials, data on newer antifungal agents, and expert opinion and recommendations.

 

ADVANCES IN ATOPIC DERMATITIS: EXPERT INSIGHTS INTO NEW AND EMERGING THERAPIES

Atopic dermatitis (AD) is a chronic, inflammatory, relapsing disorder that can result from a number of different factors including genetics, immune system dysfunction, and possibly environmental exposures. Because there is no known cure, treating patients with AD can be challenging and often frustrating for both the clinician and the patient. This CME provides information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty will discuss the 2014 AAD guidelines and other recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

 

ADVANCING THE CARE OF POST-ACNE SCARRING: EXPERT INSIGHTS INTO NEW TREATMENT OPTIONS.

Optimal management of patients with atrophic facial scars of acne vulgaris requires mindfulness of the patient's psychosocial burden; familiarity with the latest evidence-based data on efficacy and safety of available treatment modalities; and the ability to match a patient's skin type, unique scar formation, and desired outcomes with the most appropriate treatment. During this CME-accredited activity, a panel of experts will address barriers to optimal treatment through presentations integrating didactic content with video case studies that include relevant demonstrations of patient assessment and treatment.

 

STRATEGIES FOR OPTIMAL MANAGEMENT OF ACTINIC KERATOSIS

This series of 10 CME/CE-certified meetings was designed to educate dermatologists and dermatology NPs and PAs on the pathophysiology of AK, evidence-based management and the rationale for combination approaches, moving beyond cryotherapy alone - the current standard of care.

 

A STEP IN THE RIGHT DIRECTION: OPTIMIZING TREATMENT OUTCOMES IN TINEA PEDIS

This CME/CE/CPE series of meetings provided dermatologists, podiatrists, PAs, NPs, and retail pharmacists with guidance on appropriate use of topical antifungal treatments for tinea pedis, including evidence-based data on traditional and newer antifungal agents and expert strategies for improving patient adherence.

 

NAILING THE CURE: ADVANCING THE MANAGEMENT OF ONYCHOMYCOSIS

This CME initiative was designed to educate dermatologists and dermatology and podiatry residents who treat and manage patients with onychomycosis about the importance of correct diagnosis and appropriate treatment of this common condition as well as the benefits and limitations of new and emerging treatment agents and how to integrate them into current protocols to optimize results.

 

MANAGEMENT OF POST-ACNE SCARRING: ADVANCING THE STANDARD OF CARE

This series of CME meetings for dermatologists, NPs, PAs, and other healthcare professionals who manage atrophic facial scars of acne vulgaris featured experts addressing barriers to optimal care, focusing on benefits of a thorough patient evaluation, evidence-based treatment using new and emerging treatment, and patient-centric principles.

 

STRATEGIES FOR THE MANAGEMENT OF ACTINIC KERATOSIS

This CME initiative was designed to educate participants on evidence-based management of AK, including the rationale for combination approaches and selection of the most appropriate topical agents based on safety, adherence, and efficacy data from current and ongoing trials.